Clinical endpoints | IMV (n = 462) | NIV (n = 63) | NIV failure (n = 59) | p Value |
---|---|---|---|---|
Duration of mechanical ventilation, d, median (Q1–Q3) | 8.0 (4.0–14.0) | – | 8.0 (5.0–15.0) | 0.4352 |
Progression/regression of ARDSa, n (%) | ||||
 No change | 161 (40.1) | 18 (32.1) | 22 (43.1) | 0.4449 |
 Progression | 43 (10.7) | 5 (8.9) | 7 (13.7) | 0.7199 |
 Regression | 103 (25.7) | 4 (7.1)b | 16 (31.4)c | 0.0045 |
 Resolution | 94 (23.44) | 29 (51.8)b | 6 (11.8)c | < 0.0001 |
Limitation of life-sustaining measures, n (%) | ||||
 Decision to withhold life-sustaining measures | 124 (26.8) | 18 (28.6) | 16 (27.1) | 0.9587 |
 Decision to withdraw life-sustaining measures | 101 (21.9) | 14 (22.2) | 14 (23.7) | 0.9480 |
 Decision to withhold or withdraw life-sustaining measures | 154 (33.3) | 21 (33.3) | 20 (33.9) | 0.9962 |
  Before IMV or NIV start | 1 (0.6) | 0 (0.0) | 1 (5.0) | 0.2062 |
ICU mortalityd, n (%) | 214 (46.3) | 18 (28.6)b | 34 (57.6)c | 0.0043 |
Hospital mortalitye, n (%) | ||||
 All patients | 242 (52.8) | 25 (39.7) | 37 (62.7)c | 0.0362 |
 Patients with limitations of life-sustaining measuresf | 137 (89.0) | 17 (81.0) | 19 (95.0) | 0.3803 |